drugset / Trial / NCT00688012
Safety Study of SPC3649 in Healthy Men
RandomizedQuadruple-blindTreatment
Summary
A placebo-controlled, double-blind, randomized, single dose, dose escalating trial in healthy men to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SPC3649.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-05
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Miravirsen | Antisense oligonucleotide | — | — |